December
13
electroCore Announces New Patent for Stroke and TIA Treatment
ROCKAWAY, NJ, Dec. 13, 2021 (GLOBE NEWSWIRE) — electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine...
Keeping you current on new and follow-on investments, portfolio product and service milestones, publications and events, management and board transitions, and other developments in Tullis funds.